retatrutide triple agonist gip glp-1 glucagon What Is (RETA)? The Explained Retatrutide Obesity Triple Agonist Targeting

2023;388:e22

Chronic acid reflux can cause complications for your esophagus, such as heartburn and inflammation (esophagitis)

doi: 10.3389/fmed.2026.1763185 Received 08 December 2025 Revised 20 January 2026 Accepted 26 January 2026 Published 12 February 2026 Volume 13 - 2026 Edited by Jianbin Zhang, Dalian Medical University, China Reviewed by Theodoros Androutsakos, National and Kapodistrian University of Athens, Greece Feng Zhang, Nanjing University of Chinese Medicine, China Updates Copyright 2026 Lu and Yang

[DOI] [PubMed] [Google Scholar] 99.Hernandez A.F., Green J.B., Janmohamed S., D'Agostino R.B., Sr., Granger C.B., Jones N.P

Published January 12, 2024

Discussion To our knowledge, the findings of this study provide some of the first evidence that, among individuals with T2D, the use of GLP-1 RAs was associated with a lower risk of sight-threatening complications, including PDR, DME, and neovascular glaucoma, despite a marginally increased incidence of any DR